HDAC9 and retinoblastoma: To determine the effects of UHRF1 depletion on the therapeutic efficacy of HDAC inhibitors in vivo, we established an orthotopic xenograft model of human RB by transplanting either control or UHRF1‐knockdown Y79 RB cells intravitreally into the eyes of immunocompromised mice (Fig. 7A).